Survival and relative dose intensity of 5-fluorouracil, oxaliplatin and irinotecan in real-life treatment of metastatic colorectal cancer

Código QR

Survival and relative dose intensity of 5-fluorouracil, oxaliplatin and irinotecan in real-life treatment of metastatic colorectal cancer

Guardado en:

Detalles Bibliográficos
Autores principales:	Ilfad Blazevic, Willy Vaillant, Maud Basso, Karine Salignon
Formato:	article
Lenguaje:	EN
Publicado:	Termedia Publishing House 2020
Materias:	colorectal cancer relative dose intensity chemotherapy survival real-life. Medicine R
Acceso en línea:	https://doaj.org/article/7445ee124c9c46e69adaadea408f5fc6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Phase I Dose-Escalation Trial of an Innovative Chemotherapy Regimen Combining a Fractionated Dose of Irinotecan Plus Bevacizumab, Oxaliplatin, 5-Fluorouracil, and Folinic Acid (bFOLFIRINOX-3) in Chemorefractory Metastatic Colorectal Cancer
por: Hélène Bellio, et al.
Publicado: (2021)

Improvements in the Oral Absorption and Anticancer Efficacy of an Oxaliplatin-Loaded Solid Formulation: Pharmacokinetic Properties in Rats and Nonhuman Primates and the Effects of Oral Metronomic Dosing on Colorectal Cancer
por: Pangeni R, et al.
Publicado: (2020)

Evaluation of Antiemetic Therapy for Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin
por: Zhao Y, et al.
Publicado: (2021)

Bevacizumab plus capecitabine as later-line treatment for patients with metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines
por: Yeong Hak Bang, et al.
Publicado: (2021)

Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy
por: Nicolas Kerckhove, et al.
Publicado: (2021)

The Prognostic Significance of 5-Fluorouracil Induced Inflammation and Immuno-Modulation in Colorectal Cancer Patients
por: Abdellateif MS, et al.
Publicado: (2020)

Refractory metastatic colorectal cancer: challenges and solutions during the COVID-19 pandemic
por: Marina I. Sekacheva, et al.
Publicado: (2021)

Second-line systemic therapy for metastatic colorectal cancer (Russian Translation of Cochrane Plain Language Summary – PLS)
por: Aygel R. Zaleeva
Publicado: (2021)

An Overview of Clinical and Pathological Characteristics and Survival Rate of Colorectal Cancer in Iran
por: Sareh Hoseini, et al.
Publicado: (2014)

Colorectal Cancer in Octogenarians: Results of Treatment, a Descriptive Clinical Study
por: Elmer van Eeghen, et al.
Publicado: (2016)

Study protocol of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5-fluorouracil/Folinic acid followed by curative surgical resection in patients with hepatic Oligometastatic adenocarcinoma of the pancreas (HOLIPANC)
por: Florian Gebauer, et al.
Publicado: (2021)

Efficacy and Safety of Different Doses of Bevacizumab Combined With Pemetrexed and Platinum in First-Line Treatment of Advanced NSCLC: A Retrospective-Real World Study
por: Chun-Hua Zhou, et al.
Publicado: (2021)

Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Response to Letter]
por: Liao MZ, et al.
Publicado: (2020)

Resultados del tratamiento quirúrgico de las metástasis hepáticas por cáncer colorrectal
por: Norero,Enrique, et al.
Publicado: (2009)

A Comparison of Bevacizumab Plus TAS-102 and TAS-102 Monotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Xiaochen Chen, et al.
Publicado: (2021)

Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapy
por: Al-Keilani MS, et al.
Publicado: (2018)

Prognostic and clinic-pathological significances of HOXB8, ILK and FAT4 expression in colorectal cancer
por: Abdulwahab Abuderman, et al.
Publicado: (2020)

A Retrospective Analysis of the Effect of Irinotecan-Based Regimens in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
por: Jiaojiao Suo, et al.
Publicado: (2021)

SHORT-TERM RESULTS OF SIMULTANEOUS SURGERIES AT METASTATIC COLORECTAL CANCER
por: A. S. Zagaynov, et al.
Publicado: (2017)

Prognostic Value of Total Lymph Node Identified and Ratio of Lymph Nodes in Resected Colorectal Cancer
por: Leila Ghahramani, et al.
Publicado: (2013)

Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study
por: Chunxia Li, et al.
Publicado: (2021)

Delivery of Rapamycin by Liposomes Synergistically Enhances the Chemotherapy Effect of 5-Fluorouracil on Colorectal Cancer
por: Chen YQ, et al.
Publicado: (2021)

Bevacizumab treatment in the elderly patient with metastatic colorectal cancer
por: Di Bartolomeo M, et al.
Publicado: (2015)

Modern perspectives in sequential therapy for metastatic colorectal cancer with reference to the use of regorafenib
por: M. I. Sekacheva, et al.
Publicado: (2020)

Prediagnostic Blood Selenium Status and Mortality among Patients with Colorectal Cancer in Western European Populations
por: Jacqueline Roshelli Baker, et al.
Publicado: (2021)

Molecular Subclassification Based on Crosstalk Analysis Improves Prediction of Prognosis in Colorectal Cancer
por: Xiaohua Liu, et al.
Publicado: (2021)

Impact of Socioeconomic Status on Cancer Incidence Risk, Cancer Staging, and Survival of Patients with Colorectal Cancer under Universal Health Insurance Coverage in Taiwan
por: Wei-Yin Kuo, et al.
Publicado: (2021)

Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
por: Zhen Zeng, et al.
Publicado: (2018)

FDG PET/CT in follow UP patients with colorectal carcinoma after adjuvant chemotherapy
por: Remon Zaher Elia, et al.
Publicado: (2021)

Metastatic Rectal Carcinoma with Long-Term Remission due to Modern Multimodality Treatment
por: Natalja Eigeliene, et al.
Publicado: (2021)

Elevated Neutrophil-to-Lymphocyte Ratio in Perioperative Periods is Suggestive of Poor Prognosis in Patients with Colorectal Cancer
por: Kim JH, et al.
Publicado: (2021)

Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients
por: Benedikt Hoeh, et al.
Publicado: (2021)

Identification of an Autophagy-Related Gene Signature for the Prediction of Prognosis in Early-Stage Colorectal Cancer
por: Xu-tao Lin, et al.
Publicado: (2021)

Prognostic Value of Sarcopenia in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil
por: Mateusz Malik, et al.
Publicado: (2021)

Combined Therapeutic Effects of 131I-Labeled and 5Fu-Loaded Multifunctional Nanoparticles in Colorectal Cancer
por: Wu P, et al.
Publicado: (2020)

Exosomal miR-122-5p is Related to the Degree of Myelosuppression Caused by Chemotherapy in Patients with Colorectal Cancer
por: Chen J, et al.
Publicado: (2021)

Development and Validation of a Predictive Scoring System for Colorectal Cancer Patients With Liver Metastasis: A Population-Based Study
por: Yinghao Cao, et al.
Publicado: (2021)

Clinical significance of mucinous component in colorectal adenocarcinoma: a propensity score-matched study
por: Chuanwang Yan, et al.
Publicado: (2021)

Additional baricitinib loading dose improves clinical outcome in COVID-19
por: Hasan Md Jahidul, et al.
Publicado: (2020)

High-dose chemotherapy following autologous hematopoietic stem cell transplantation for multiple myeloma in the real world setting. Single-center experience
por: Nikita E. Mochkin, et al.
Publicado: (2020)